Tumor necrosis factor receptor 1 associated periodic syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:32960OMIM:142680E85.0
Who is this for?
Show terms as
1FDA treatments1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tumor necrosis factor receptor 1 associated periodic syndrome, most commonly known by its abbreviation TRAPS, is a rare inherited condition that causes repeated episodes of fever and inflammation throughout the body. It used to be called 'familial Hibernian fever' because it was first described in families of Irish and Scottish descent, though we now know it affects people of all backgrounds. TRAPS is caused by changes (mutations) in a gene called TNFRSF1A, which controls a protein that helps regulate the body's inflammatory response. When this gene does not work properly, the immune system becomes overactive and triggers episodes of fever and inflammation that can last days to weeks at a time. During a flare, people with TRAPS may experience high fevers, severe abdominal pain, chest pain, muscle aches, skin rashes, and swelling around the eyes. These episodes can be very disabling and unpredictable. Between attacks, many people feel relatively well, though some have ongoing low-level inflammation. Treatment has improved significantly in recent years. Anti-inflammatory medications, including corticosteroids, have long been used to shorten attacks. Biologic therapies that target specific parts of the immune system — especially a drug called canakinumab (Ilaris), which is FDA-approved for TRAPS — have been a major advance. Another biologic, etanercept, is sometimes used but with variable results. The main long-term concern is a complication called amyloidosis, where inflammatory proteins build up in organs, particularly the kidneys. With proper monitoring and treatment, many people with TRAPS can manage their symptoms and reduce this risk.

Also known as:

Key symptoms:

Recurring high fevers lasting days to weeksSevere abdominal pain and crampingChest pain, sometimes with difficulty breathingMuscle pain and tenderness, often moving from one area to anotherSkin rash that may be red, patchy, or migratorySwelling and puffiness around the eyes (periorbital edema)Joint pain and swellingSwollen lymph nodesHeadacheFatigue and general feeling of being unwell during attacksNausea and vomitingScrotal pain and swelling in males

Clinical phenotype terms (40)— hover any for plain English
ErysipelasHP:0001055Abnormal myocardium morphologyHP:0001637PleuritisHP:0002102
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

3 events
Mar 2026High-Intensity Laser Therapy for Trapezius Myofascial Pain (HILT-TRAP Study)

Neveen Abd El Maksoad Kohaf — NA

TrialNOT YET RECRUITING
Sep 2025Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins

Kun-Ta Chou

TrialNOT YET RECRUITING
May 2016TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

Universitaire Ziekenhuizen KU Leuven — PHASE4

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

ILARIS

canakinumab· Novartis Pharmaceuticals Corporation

indicated for the treatment of Tumor Necrosis Factor (TNF) Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients

No actively recruiting trials found for Tumor necrosis factor receptor 1 associated periodic syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Tumor necrosis factor receptor 1 associated periodic syndrome community →

Specialists

1 foundView all specialists →

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tumor necrosis factor receptor 1 associated periodic syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tumor necrosis factor receptor 1 associated periodic syndromeForum →

No community posts yet. Be the first to share your experience with Tumor necrosis factor receptor 1 associated periodic syndrome.

Start the conversation →

Latest news about Tumor necrosis factor receptor 1 associated periodic syndrome

Disease timeline:

New recruiting trial: TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

A new clinical trial is recruiting patients for Tumor necrosis factor receptor 1 associated periodic syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific mutation do I have in the TNFRSF1A gene, and what does that mean for my risk of complications like amyloidosis?,Should my family members be tested for the same mutation?,Is canakinumab (Ilaris) the right treatment for me, and how will we know if it is working?,How often should I have blood and urine tests to check for kidney damage or amyloidosis?,What should I do at home when a flare starts — is there a rescue treatment plan?,Are there any clinical trials I should know about for TRAPS?,What are the long-term risks if my inflammation is not fully controlled?

Common questions about Tumor necrosis factor receptor 1 associated periodic syndrome

What is Tumor necrosis factor receptor 1 associated periodic syndrome?

Tumor necrosis factor receptor 1 associated periodic syndrome, most commonly known by its abbreviation TRAPS, is a rare inherited condition that causes repeated episodes of fever and inflammation throughout the body. It used to be called 'familial Hibernian fever' because it was first described in families of Irish and Scottish descent, though we now know it affects people of all backgrounds. TRAPS is caused by changes (mutations) in a gene called TNFRSF1A, which controls a protein that helps regulate the body's inflammatory response. When this gene does not work properly, the immune system be

How is Tumor necrosis factor receptor 1 associated periodic syndrome inherited?

Tumor necrosis factor receptor 1 associated periodic syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Tumor necrosis factor receptor 1 associated periodic syndrome?

1 specialists and care centers treating Tumor necrosis factor receptor 1 associated periodic syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.